Matthew Plunkett, EVP, Chief Business Officer at CTI BIOPHARMA CORP (CTIC), sold 12,700 shares at $1.20 ($15K) on 2016-01-04, disclosed to the SEC on 2016-01-06.
Open-market sale of $15k CTIC by EVP, Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.20 | 1,600 | $2K | 12.4% |
| 2 | $1.20 | 1,898 | $2K | 14.8% |
| 3 | $1.20 | 1,600 | $2K | 12.5% |
| 4 | $1.21 | 800 | $964 | 6.3% |
| 5 | $1.21 | 1,900 | $2K | 14.9% |
| 6 | $1.21 | 800 |
| $968 |
| 6.3% |
| 7 | $1.22 | 1,700 | $2K | 13.5% |
| 8 | $1.23 | 800 | $984 | 6.4% |
| 9 | $1.24 | 300 | $371 | 2.4% |
| 10 | $1.24 | 202 | $250 | 1.6% |
| 11 | $1.24 | 300 | $372 | 2.4% |
| 12 | $1.25 | 600 | $750 | 4.9% |
| 13 | $1.26 | 200 | $252 | 1.6% |
| Total | $1.21 avg | 12,700 | $15K | 100% |
| Filing → |
| CTIC | SELL | 2015-12-04 | $9K | — | Filing → |
| CTIC | SELL | 2015-11-06 | $14K | — | Filing → |
| CTIC | SELL | 2015-10-07 | $15K | — | Filing → |